Arizona Parkinson's Disease Center Predictors of Parkinson’s Disease and Parkinson’s Disease-Associated Dementia


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Scottsdale/Phoenix, Arizona: 06-006912
    Sponsor Protocol Number: 06-006912

About this study

The purpose of this study is ongoing longitudinal clinicopathologic studies of normal aging and Parkinson's Disease subjects. Specific projects of motor, non-motor and peripheral manifestations of Parkinson’s disease (PD) as possible early markers of PD onset in otherwise asymptomatic elderly people. Cognitive and non-cognitive markers of eventual dementia onset in previously non-demented persons with PD.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Patients with Parkinson’s disease (PD)
  • Normal healthy control subjects

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Charles Adler, M.D., Ph.D.

Contact us for the latest status

Contact information:

Amy Duffy CCRP



Mayo Clinic Footer